Cargando…
Comment on: Zhang et al. Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes: Evidence From Meta-Analysis of 18 Studies. Diabetes Care 2012;35:1388–1393
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526245/ https://www.ncbi.nlm.nih.gov/pubmed/23264301 http://dx.doi.org/10.2337/dc12-1993 |
| _version_ | 1782253527543840768 |
|---|---|
| author | Lapice, Emanuela Cocozza, Sara Riccardi, Gabriele Vaccaro, Olga |
| author_facet | Lapice, Emanuela Cocozza, Sara Riccardi, Gabriele Vaccaro, Olga |
| author_sort | Lapice, Emanuela |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3526245 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35262452014-01-01 Comment on: Zhang et al. Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes: Evidence From Meta-Analysis of 18 Studies. Diabetes Care 2012;35:1388–1393 Lapice, Emanuela Cocozza, Sara Riccardi, Gabriele Vaccaro, Olga Diabetes Care Online Letters: Comments and Responses American Diabetes Association 2013-01 2012-12-11 /pmc/articles/PMC3526245/ /pubmed/23264301 http://dx.doi.org/10.2337/dc12-1993 Text en © 2013 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Online Letters: Comments and Responses Lapice, Emanuela Cocozza, Sara Riccardi, Gabriele Vaccaro, Olga Comment on: Zhang et al. Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes: Evidence From Meta-Analysis of 18 Studies. Diabetes Care 2012;35:1388–1393 |
| title | Comment on: Zhang et al. Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes: Evidence From Meta-Analysis of 18 Studies. Diabetes Care 2012;35:1388–1393 |
| title_full | Comment on: Zhang et al. Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes: Evidence From Meta-Analysis of 18 Studies. Diabetes Care 2012;35:1388–1393 |
| title_fullStr | Comment on: Zhang et al. Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes: Evidence From Meta-Analysis of 18 Studies. Diabetes Care 2012;35:1388–1393 |
| title_full_unstemmed | Comment on: Zhang et al. Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes: Evidence From Meta-Analysis of 18 Studies. Diabetes Care 2012;35:1388–1393 |
| title_short | Comment on: Zhang et al. Peroxisome Proliferator–Activated Receptor γ Polymorphism Pro12Ala Is Associated With Nephropathy in Type 2 Diabetes: Evidence From Meta-Analysis of 18 Studies. Diabetes Care 2012;35:1388–1393 |
| title_sort | comment on: zhang et al. peroxisome proliferator–activated receptor γ polymorphism pro12ala is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies. diabetes care 2012;35:1388–1393 |
| topic | Online Letters: Comments and Responses |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526245/ https://www.ncbi.nlm.nih.gov/pubmed/23264301 http://dx.doi.org/10.2337/dc12-1993 |
| work_keys_str_mv | AT lapiceemanuela commentonzhangetalperoxisomeproliferatoractivatedreceptorgpolymorphismpro12alaisassociatedwithnephropathyintype2diabetesevidencefrommetaanalysisof18studiesdiabetescare20123513881393 AT cocozzasara commentonzhangetalperoxisomeproliferatoractivatedreceptorgpolymorphismpro12alaisassociatedwithnephropathyintype2diabetesevidencefrommetaanalysisof18studiesdiabetescare20123513881393 AT riccardigabriele commentonzhangetalperoxisomeproliferatoractivatedreceptorgpolymorphismpro12alaisassociatedwithnephropathyintype2diabetesevidencefrommetaanalysisof18studiesdiabetescare20123513881393 AT vaccaroolga commentonzhangetalperoxisomeproliferatoractivatedreceptorgpolymorphismpro12alaisassociatedwithnephropathyintype2diabetesevidencefrommetaanalysisof18studiesdiabetescare20123513881393 |